Sep 26 |
Inozyme Pharma Presents New Data at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting
|
Sep 12 |
Inozyme draws buy at Stifel on lead asset
|
Sep 12 |
This AutoNation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
|
Aug 29 |
Inozyme Pharma to Participate at the 2024 Wells Fargo Healthcare Conference
|
Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Aug 18 |
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
|
Aug 13 |
Inozyme draws Buy at Jefferies on rare disease opportunity
|
Aug 11 |
Institutional owners may consider drastic measures as Inozyme Pharma, Inc.'s (NASDAQ:INZY) recent US$49m drop adds to long-term losses
|
Aug 6 |
Inozyme Pharma GAAP EPS of -$0.44
|
Aug 6 |
Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights
|